Moran Kevin Patrick 4
4 · Vanda Pharmaceuticals Inc. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Moran Kevin Patrick
SVP, CFO & Treasurer
Transactions
- Tax Payment
Common Stock
2025-03-01$4.76/sh−26,941$128,239→ 328,822 total
Holdings
- 635(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs.